Dernières nouvelles pour Anixa Biosciences (NASDAQ:ANIX) Stock

ANIXA BIOSCIENCES INC

Anixa Biosciences

Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

Morgan Stanley analyst Vikram Purohit assumes Recursion Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NASDAQ">RXRX</a>) with a Equal-Weight rating and announces Price Target of $5.

News

Price Target

Initiation

Analyst Ratings

RXRX

Morgan Stanley Assumes Recursion Pharmaceuticals at Equal-Weight, Announces Price Target of $5

Morgan Stanley analyst Sean Laaman assumes Axsome Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXSM#NASDAQ">AXSM</a>) with a Overweight rating and announces Price Target of $190.

AXSM

Morgan Stanley Assumes Axsome Therapeutics at Overweight, Announces Price Target of $190

Morgan Stanley analyst Sean Laaman assumes Disc Medicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRON#NASDAQ">IRON</a>) with a Overweight rating and announces Price Target of $85.

IRON

Morgan Stanley Assumes Disc Medicine at Overweight, Announces Price Target of $85

In the current session, the stock is trading at $1522.98, after a 0.75% spike. Over the past month, TransDigm Gr Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDG#NYSE">TDG</a>) stock increased by 5.43%, and in the past year, by 19.49%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1751564405_0.png" alt="Past Year Chart" />

<h3>Comparing TransDigm Gr P/E Against Its Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of the 120.59 in the Aerospace &amp; Defense industry, TransDigm Gr Inc. has a lower P/E ratio of 50.98. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1751564405_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Markets

P/E Ratio Insights for TransDigm Gr

Shares of CoreWeave Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>) traded higher on Thursday with gains accelerating into the close. The company announced it became the first AI cloud provider to deploy NVIDIA Corp&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) new <a href="https://www.benzinga.com/pressreleases/25/07/n46249941/coreweave-becomes-first-hyperscaler-to-deploy-nvidia-gb300-nvl72-platform">GB300 NVL72 platform</a>.
What To Know: CoreWeave announced plans to significantly scale deployments worldwide after highlighting its first GB300 NVL72 deployment on Thursday. 
The GB300 NVL72 brings an upgrade in AI reasoning performance, offering as much as a 10x boost in user responsiveness and a 50x jump in inference output compared to the previous Nvidia Hopper architecture.
CoreWeave said it worked with Dell, Switch and Vertiv to roll out the new infrastructure, which is tightly integrated with CoreWeave's Kubernetes and observability stack. 
&#8220;CoreWeave is constantly working to push the boundaries of AI development further, deploying the bleeding-edge cloud capabilities required to train the next generation of AI models,&#8221; said Peter Salanki, co-founder and CTO of CoreWeave.
&#8220;We&#8217;re proud to be the first to stand up this transformative platform and help innovators prepare for the next exciting wave of AI.&#8221;
CoreWeave shares were seeing some early momentum Thursday morning, but gains accelerated in the afternoon after the company highlighted the deployment milestone. <a href="http://benzinga.com/quote/NVDA">Nvidia</a> also hit all-time highs on Thursday, climbing above $160 before pulling back slightly ahead of the close.
CoreWeave went public in March in an IPO at $40 per share. Despite stumbling a bit out of the gates, shares have soared in recent months as the rise of generative AI and large language models continues to fuel incredible demand for high-performance computing infrastructure.
CoreWeave continues to see strong interest from investors. It was one of the <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/07/46205646/exclusive-june-20-most-searched-tickers-on-benzinga-pro-where-do-coreweave-nvidia-apple-stock-rank">most searched</a> stocks on <a href="http://pro.benzinga.com">Benzinga Pro</a> last month as AI-related names continue to lead markets higher. CoreWeave shares closed Thursday&#8217;s shortened trading session about $22 below all-time highs of $187. 
CRWV Price Action: CoreWeave shares closed Thursday up 8.85% at $165.20, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga pro.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/07/46236448/exclusive-2025s-first-half-most-searched-tickers-on-benzinga-pro-where-do-nvidia-tesla-apple-stock-rank">EXCLUSIVE: 2025&#8217;s First Half Most-Searched Tickers On Benzinga Pro — Where Do Nvidia, Tesla, Apple Stock Rank?</a></li>
</ul>
Image Via Shutterstock.

Movers

CRWV

NVDA

CoreWeave Stock Rallied On Thursday: What Happened?

Morgan Stanley analyst Sean Laaman assumes Certara (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERT#NASDAQ">CERT</a>) with a Equal-Weight rating and announces Price Target of $16.

CERT

Morgan Stanley Assumes Certara at Equal-Weight, Announces Price Target of $16

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/03/25</td>
<td>$90.00</td>
<td>$86.9K</td>
<td>12.7K</td>
<td>4.9K</td>
</tr>
<tr>
<td>COIN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>08/15/25</td>
<td>$400.00</td>
<td>$91.3K</td>
<td>8.4K</td>
<td>2.1K</td>
</tr>
<tr>
<td>SOFI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/25/25</td>
<td>$14.50</td>
<td>$206.8K</td>
<td>1.1K</td>
<td>636</td>
</tr>
<tr>
<td>V</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>07/11/25</td>
<td>$357.50</td>
<td>$30.0K</td>
<td>171</td>
<td>345</td>
</tr>
<tr>
<td>WFC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$90.00</td>
<td>$51.0K</td>
<td>16</td>
<td>257</td>
</tr>
<tr>
<td>BULL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$10.00</td>
<td>$44.5K</td>
<td>2.7K</td>
<td>236</td>
</tr>
<tr>
<td>AXP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>07/18/25</td>
<td>$330.00</td>
<td>$36.9K</td>
<td>1.1K</td>
<td>195</td>
</tr>
<tr>
<td>MA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$585.00</td>
<td>$94.0K</td>
<td>100</td>
<td>137</td>
</tr>
<tr>
<td>AFRM</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$70.00</td>
<td>$100.4K</td>
<td>678</td>
<td>80</td>
</tr>
<tr>
<td>JPM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/17/27</td>
<td>$380.00</td>
<td>$31.0K</td>
<td>40</td>
<td>16</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• For HOOD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>), we notice a call option trade that happens to be bearish, is expiring today. Parties traded 200 contract(s) at a $90.00 strike. The total cost received by the writing party (or parties) was $86.9K, with a price of $435.0 per contract. There were 12759 open contracts at this strike prior to today, and today 4928 contract(s) were bought and sold. 
• For COIN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), we notice a call option sweep that happens to be neutral, expiring in 43 day(s) on August 15, 2025. This event was a transfer of 54 contract(s) at a $400.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $91.3K, with a price of $1692.0 per contract. There were 8492 open contracts at this strike prior to today, and today 2187 contract(s) were bought and sold. 
• Regarding SOFI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>), we observe a call option trade with bearish sentiment. It expires in 22 day(s) on July 25, 2025. Parties traded 507 contract(s) at a $14.50 strike. The total cost received by the writing party (or parties) was $206.8K, with a price of $408.0 per contract. There were 1196 open contracts at this strike prior to today, and today 636 contract(s) were bought and sold. 
• For V (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>), we notice a call option trade that happens to be neutral, expiring in 8 day(s) on July 11, 2025. This event was a transfer of 68 contract(s) at a $357.50 strike. The total cost received by the writing party (or parties) was $30.0K, with a price of $442.5 per contract. There were 171 open contracts at this strike prior to today, and today 345 contract(s) were bought and sold. 
• Regarding WFC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>), we observe a put option sweep with bearish sentiment. It expires in 78 day(s) on September 19, 2025. Parties traded 65 contract(s) at a $90.00 strike. This particular put needed to be split into 12 different trades to become filled. The total cost received by the writing party (or parties) was $51.0K, with a price of $785.0 per contract. There were 16 open contracts at this strike prior to today, and today 257 contract(s) were bought and sold. 
• For BULL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BULL#NASDAQ">BULL</a>), we notice a call option trade that happens to be bearish, expiring in 78 day(s) on September 19, 2025. This event was a transfer of 100 contract(s) at a $10.00 strike. The total cost received by the writing party (or parties) was $44.5K, with a price of $445.0 per contract. There were 2769 open contracts at this strike prior to today, and today 236 contract(s) were bought and sold. 
• For AXP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>), we notice a call option sweep that happens to be neutral, expiring in 15 day(s) on July 18, 2025. This event was a transfer of 44 contract(s) at a $330.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $36.9K, with a price of $840.0 per contract. There were 1142 open contracts at this strike prior to today, and today 195 contract(s) were bought and sold. 
• Regarding MA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>), we observe a put option sweep with bullish sentiment. It expires in 78 day(s) on September 19, 2025. Parties traded 33 contract(s) at a $585.00 strike. This particular put needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $94.0K, with a price of $2850.0 per contract. There were 100 open contracts at this strike prior to today, and today 137 contract(s) were bought and sold. 
• For AFRM (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>), we notice a put option trade that happens to be neutral, expiring in 197 day(s) on January 16, 2026. This event was a transfer of 80 contract(s) at a $70.00 strike. The total cost received by the writing party (or parties) was $100.4K, with a price of $1255.0 per contract. There were 678 open contracts at this strike prior to today, and today 80 contract(s) were bought and sold. 
• For JPM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), we notice a call option sweep that happens to be bearish, expiring in 897 day(s) on December 17, 2027. This event was a transfer of 16 contract(s) at a $380.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $31.0K, with a price of $1937.0 per contract. There were 40 open contracts at this strike prior to today, and today 16 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

AFRM

BULL

COIN

HOOD

SOFI

10 Financials Stocks With Whale Alerts In Today's Session

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Below are some instances of options activity happening in the Consumer Discretionary sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/11/25</td>
<td>$320.00</td>
<td>$148.0K</td>
<td>10.5K</td>
<td>18.9K</td>
</tr>
<tr>
<td>BABA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$110.00</td>
<td>$25.6K</td>
<td>4.0K</td>
<td>2.1K</td>
</tr>
<tr>
<td>F</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$14.85</td>
<td>$79.0K</td>
<td>28.1K</td>
<td>1.3K</td>
</tr>
<tr>
<td>JD</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/20/26</td>
<td>$28.00</td>
<td>$30.7K</td>
<td>1.9K</td>
<td>700</td>
</tr>
<tr>
<td>XPEV</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$19.00</td>
<td>$26.2K</td>
<td>295</td>
<td>436</td>
</tr>
<tr>
<td>CAVA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$75.00</td>
<td>$47.8K</td>
<td>1.2K</td>
<td>213</td>
</tr>
<tr>
<td>HOG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$23.00</td>
<td>$33.8K</td>
<td>653</td>
<td>176</td>
</tr>
<tr>
<td>SBUX</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>07/11/25</td>
<td>$89.00</td>
<td>$36.7K</td>
<td>1.2K</td>
<td>165</td>
</tr>
<tr>
<td>RCL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$410.00</td>
<td>$143.4K</td>
<td>111</td>
<td>102</td>
</tr>
<tr>
<td>NKE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/11/25</td>
<td>$69.00</td>
<td>$48.0K</td>
<td>271</td>
<td>71</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• Regarding TSLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), we observe a call option sweep with bearish sentiment. It expires in 8 day(s) on July 11, 2025. Parties traded 200 contract(s) at a $320.00 strike. This particular call needed to be split into 19 different trades to become filled. The total cost received by the writing party (or parties) was $148.0K, with a price of $740.0 per contract. There were 10560 open contracts at this strike prior to today, and today 18921 contract(s) were bought and sold. 
• For BABA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), we notice a call option sweep that happens to be bearish, expiring in 43 day(s) on August 15, 2025. This event was a transfer of 50 contract(s) at a $110.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $25.6K, with a price of $513.0 per contract. There were 4089 open contracts at this strike prior to today, and today 2173 contract(s) were bought and sold. 
• Regarding F (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>), we observe a call option sweep with bullish sentiment. It expires in 561 day(s) on January 15, 2027. Parties traded 1000 contract(s) at a $14.85 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $79.0K, with a price of $79.0 per contract. There were 28155 open contracts at this strike prior to today, and today 1336 contract(s) were bought and sold. 
• For JD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>), we notice a put option trade that happens to be neutral, expiring in 260 day(s) on March 20, 2026. This event was a transfer of 150 contract(s) at a $28.00 strike. The total cost received by the writing party (or parties) was $30.7K, with a price of $205.0 per contract. There were 1941 open contracts at this strike prior to today, and today 700 contract(s) were bought and sold. 
• For XPEV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>), we notice a call option trade that happens to be bullish, expiring in 43 day(s) on August 15, 2025. This event was a transfer of 199 contract(s) at a $19.00 strike. The total cost received by the writing party (or parties) was $26.2K, with a price of $132.0 per contract. There were 295 open contracts at this strike prior to today, and today 436 contract(s) were bought and sold. 
• Regarding CAVA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAVA#NYSE">CAVA</a>), we observe a call option trade with bearish sentiment. It expires in 78 day(s) on September 19, 2025. Parties traded 29 contract(s) at a $75.00 strike. The total cost received by the writing party (or parties) was $47.8K, with a price of $1650.0 per contract. There were 1269 open contracts at this strike prior to today, and today 213 contract(s) were bought and sold. 
• Regarding HOG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HOG#NYSE">HOG</a>), we observe a call option trade with bearish sentiment. It expires in 15 day(s) on July 18, 2025. Parties traded 123 contract(s) at a $23.00 strike. The total cost received by the writing party (or parties) was $33.8K, with a price of $275.0 per contract. There were 653 open contracts at this strike prior to today, and today 176 contract(s) were bought and sold. 
• Regarding SBUX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>), we observe a call option trade with neutral sentiment. It expires in 8 day(s) on July 11, 2025. Parties traded 65 contract(s) at a $89.00 strike. The total cost received by the writing party (or parties) was $36.7K, with a price of $566.0 per contract. There were 1289 open contracts at this strike prior to today, and today 165 contract(s) were bought and sold. 
• For RCL (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>), we notice a call option sweep that happens to be bullish, expiring in 197 day(s) on January 16, 2026. This event was a transfer of 88 contract(s) at a $410.00 strike. This particular call needed to be split into 18 different trades to become filled. The total cost received by the writing party (or parties) was $143.4K, with a price of $1630.0 per contract. There were 111 open contracts at this strike prior to today, and today 102 contract(s) were bought and sold. 
• For NKE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>), we notice a call option trade that happens to be bearish, expiring in 8 day(s) on July 11, 2025. This event was a transfer of 64 contract(s) at a $69.00 strike. The total cost received by the writing party (or parties) was $48.0K, with a price of $750.0 per contract. There were 271 open contracts at this strike prior to today, and today 71 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BABA

CAVA

SBUX

TSLA

XPEV

10 Consumer Discretionary Stocks With Whale Alerts In Today's Session

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/11/25</td>
<td>$160.00</td>
<td>$25.2K</td>
<td>88.6K</td>
<td>115.8K</td>
</tr>
<tr>
<td>CRWV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/03/25</td>
<td>$160.00</td>
<td>$51.2K</td>
<td>3.7K</td>
<td>10.7K</td>
</tr>
<tr>
<td>AAPL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$235.00</td>
<td>$104.8K</td>
<td>19.7K</td>
<td>7.1K</td>
</tr>
<tr>
<td>ORCL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$250.00</td>
<td>$110.0K</td>
<td>3.9K</td>
<td>5.3K</td>
</tr>
<tr>
<td>MARA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/11/25</td>
<td>$17.00</td>
<td>$52.6K</td>
<td>2.9K</td>
<td>3.7K</td>
</tr>
<tr>
<td>MSTR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/11/25</td>
<td>$400.00</td>
<td>$57.7K</td>
<td>15.5K</td>
<td>3.3K</td>
</tr>
<tr>
<td>AVGO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/11/25</td>
<td>$275.00</td>
<td>$90.1K</td>
<td>2.1K</td>
<td>2.8K</td>
</tr>
<tr>
<td>QUBT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/03/25</td>
<td>$20.00</td>
<td>$40.9K</td>
<td>3.6K</td>
<td>2.2K</td>
</tr>
<tr>
<td>SEDG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$25.00</td>
<td>$44.0K</td>
<td>1.6K</td>
<td>1.5K</td>
</tr>
<tr>
<td>SMCI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$55.00</td>
<td>$29.7K</td>
<td>9.8K</td>
<td>1.4K</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• For NVDA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), we notice a call option trade that happens to be bullish, expiring in 8 day(s) on July 11, 2025. This event was a transfer of 100 contract(s) at a $160.00 strike. The total cost received by the writing party (or parties) was $25.2K, with a price of $252.0 per contract. There were 88681 open contracts at this strike prior to today, and today 115803 contract(s) were bought and sold. 
• For CRWV (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>), we notice a call option sweep that happens to be bullish, is expiring today. Parties traded 150 contract(s) at a $160.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $51.2K, with a price of $345.0 per contract. There were 3751 open contracts at this strike prior to today, and today 10708 contract(s) were bought and sold. 
• For AAPL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), we notice a call option trade that happens to be bullish, expiring in 43 day(s) on August 15, 2025. This event was a transfer of 699 contract(s) at a $235.00 strike. The total cost received by the writing party (or parties) was $104.8K, with a price of $150.0 per contract. There were 19715 open contracts at this strike prior to today, and today 7135 contract(s) were bought and sold. 
• For ORCL (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>), we notice a call option sweep that happens to be bearish, expiring in 15 day(s) on July 18, 2025. This event was a transfer of 500 contract(s) at a $250.00 strike. This particular call needed to be split into 26 different trades to become filled. The total cost received by the writing party (or parties) was $110.0K, with a price of $220.0 per contract. There were 3907 open contracts at this strike prior to today, and today 5310 contract(s) were bought and sold. 
• For MARA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>), we notice a put option sweep that happens to be bearish, expiring in 8 day(s) on July 11, 2025. This event was a transfer of 1548 contract(s) at a $17.00 strike. This particular put needed to be split into 46 different trades to become filled. The total cost received by the writing party (or parties) was $52.6K, with a price of $34.0 per contract. There were 2904 open contracts at this strike prior to today, and today 3793 contract(s) were bought and sold. 
• For MSTR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), we notice a call option trade that happens to be bearish, expiring in 8 day(s) on July 11, 2025. This event was a transfer of 50 contract(s) at a $400.00 strike. The total cost received by the writing party (or parties) was $57.7K, with a price of $1155.0 per contract. There were 15522 open contracts at this strike prior to today, and today 3348 contract(s) were bought and sold. 
• For AVGO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), we notice a call option trade that happens to be bullish, expiring in 8 day(s) on July 11, 2025. This event was a transfer of 175 contract(s) at a $275.00 strike. The total cost received by the writing party (or parties) was $90.1K, with a price of $515.0 per contract. There were 2101 open contracts at this strike prior to today, and today 2883 contract(s) were bought and sold. 
• For QUBT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>), we notice a call option sweep that happens to be bullish, is expiring today. Parties traded 372 contract(s) at a $20.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $40.9K, with a price of $110.0 per contract. There were 3648 open contracts at this strike prior to today, and today 2240 contract(s) were bought and sold. 
• Regarding SEDG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>), we observe a put option trade with bullish sentiment. It expires in 197 day(s) on January 16, 2026. Parties traded 78 contract(s) at a $25.00 strike. The total cost received by the writing party (or parties) was $44.0K, with a price of $565.0 per contract. There were 1671 open contracts at this strike prior to today, and today 1500 contract(s) were bought and sold. 
• For SMCI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>), we notice a call option trade that happens to be bullish, expiring in 43 day(s) on August 15, 2025. This event was a transfer of 100 contract(s) at a $55.00 strike. The total cost received by the writing party (or parties) was $29.7K, with a price of $297.0 per contract. There were 9817 open contracts at this strike prior to today, and today 1490 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AAPL

AVGO

MARA

MSTR

ORCL

QUBT

SEDG

SMCI

10 Information Technology Stocks Whale Activity In Today's Session

One investor recently turned to Reddit&#8217;s <a href="https://www.reddit.com/r/stocks/comments/1lkq7v7/what_percentage_of_cash_are_you_holding_now/">r/stocks</a> community with a simple but revealing question: &#8220;What percentage of cash are you holding now?&#8221; With markets pushing new highs and macro risks looming, he explained he was sitting on 25% cash, citing high price-to-earnings ratios, global tensions and general unease as his reasons for holding back.
<h2 class="wp-block-heading">A Divided Crowd: From All-In To All-Out</h2>
The thread drew comments from people across the investing spectrum. Some were fully invested, others had pulled out almost entirely. The most commonly cited ranges were between 0% and 5% for long-term investors, and up to 50% or more for those bracing for a downturn.
&#8220;<a href="https://www.benzinga.com/personal-finance/management/25/06/45848783/need-quick-cash-christine-benzs-top-5-tips-to-boost-your-emergency-fund">Emergency fund</a> only,&#8221; one top commenter said. &#8220;There are always risks and you miss out on a lot of potential by sitting on the sidelines. Most people <a href="https://www.benzinga.com/markets/equities/25/04/44610661/why-timing-the-market-is-a-terrible-idea">fail in trying to time the market</a> like this.&#8221;
Don't Miss:
<ul class="wp-block-list">
<li>Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a></li>
<li>Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation. </a></li>
</ul>
Another added, &#8220;I'm about 80% cash&#8230; I know I'm an idiot statistically speaking. Timing the market is bad. I get it. But damn it. I watch our government behave like children and freak the f out.&#8221;
Some users held cash strictly because of interest rates. &#8220;Cash is paying 4.2%, and many mortgages are locked in at less than that,&#8221; one person noted. &#8220;The opportunity cost of avoiding what appears to be a teetering market is pretty low.&#8221;
Others stayed aggressive. &#8220;I don't keep cash lying around, that's a waste of resources. You need to be in the market,&#8221; a user said.
Still, many agreed that the market feels unusual right now. One wrote, &#8220;If things aren't <a href="https://www.benzinga.com/money/is-it-a-good-time-to-invest-in-the-stock-market">objectively risky</a> right now, then when? Risk should have tanked this market twice over, but everything gets shrugged off.&#8221;
Trending: GoSun's Breakthrough Rooftop EV Charger Already Has 2,000+ Units Reserved — <a href="https://www.benzinga.com/money/meet-the-company-seeking-to-give-americans-energy-independence-and-learn-how-you-can-become-an-early-investor">Become an Investor in This $41.3M Clean Energy Brand Today</a>&nbsp;
Some admitted to recent panic selling, missing rallies, or simply feeling confused. &#8220;I pulled out in February/March before <a href="https://www.benzinga.com/markets/25/05/45486508/scott-bessent-signals-liberation-day-2-0-coming-if-countries-dont-sign-trade-deals-president-trump-has-put-them-on-notice">Liberation day</a>, convinced the sky was falling&#8230; then got back in once most of it recovered,&#8221; a commenter said. &#8220;I'm sure all I've done is incur tax events, but I know I'm not unique in this monkey behavior.&#8221;
Several mentioned they were holding 10% to 30% cash as a buffer or &#8220;dry powder.&#8221;&nbsp;
A number of investors pointed out that <a href="https://www.benzinga.com/markets/24/08/40431340/berkshires-latest-move-outpacing-the-fed-with-short-term-u-s-treasury-bills-what-buffett-knows-that">short-term Treasuries</a>, <a href="https://www.benzinga.com/money/best-high-yield-savings-accounts">high-yield savings accounts</a>, and <a href="https://www.benzinga.com/markets/bonds/25/06/46087443/money-market-funds-on-fire-as-902-billion-pours-in-why-these-safe-haven-investments-are-thriving-now">money market funds</a> were offering 4% to 5%, giving them less urgency to jump back into equities. &#8220;Why not get 4.5% on your emergency fund that's sitting around doing nothing in a savings account earning .01%?&#8221; a person asked.
Not everyone was anxious, though. &#8220;Zero. It's bull market time,&#8221; one said. Another added, &#8220;0% cash. I have no clue what's going to happen&#8230; I&#8217;ll keep putting money in every paycheck.&#8221;
One of the more reflective voices concluded, &#8220;Don't underestimate how much crazy sh&#x2A;t and risk is already priced in. A lot of people, myself included, would rather hold and have the market dip than sell and watch it pump.&#8221;
Read Next:
<ul class="wp-block-list">
<li>Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. <a href="https://www.benzinga.com/money/this-company-may-have-found-a-way-to-treat-cancer-by-tricking-the-bodys-immune-system-and-early-studies-show-some-promise-find-out-how-you-can-invest-in-the-future-of-cancer-treatment">Back a bold new approach to cancer treatment with high-growth potential.</a></li>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
</ul>
Image: Shutterstock

An Investor Asks Others, 'What Percentage Of Cash Are You Holding Now?' High P/E Ratios And Geopolitical Risk Have Him Holding Back

Senator Cynthia Lummis (R-WY) has introduced a sweeping digital asset tax reform bill aimed at modernizing how cryptocurrencies are taxed in the United States, renewing her efforts to ease <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46227149/every-new-trillion-of-debt-in-trumps-big-beautiful-bill-is-free-adertising-for-bitcoin-expert-states">regulatory burdens on digital asset users.</a>
What Happened: The legislation, <a href="https://www.lummis.senate.gov/press-releases/lummis-unveils-digital-asset-tax-legislation/">unveiled</a> on July 3, proposes to resolve several long-standing tax complications in the crypto sector, including a $300 de minimis exemption for small transactions, more practical tax treatment for mining and staking, and bringing parity between digital assets and traditional financial instruments.
"In order to maintain our competitive edge, we must change our tax code to embrace our digital economy, not burden digital asset users," Lummis said in a statement. 
She described the bill as fully paid for, designed to cut through red tape, and aimed at aligning tax rules with how digital technologies work in practice.
The bill addresses multiple areas that have been problematic for crypto users:
<ul class="wp-block-list">
<li>A de minimis rule would exempt gains from small transactions, up to $300 per transaction and capped at $5,000 annually, easing tax tracking for everyday crypto use such as small purchases.</li>
<li>Digital asset lending agreements would no longer be treated as taxable events, aligning crypto lending with the well-established securities lending framework.</li>
<li>A wash sale rule would now apply to digital assets, closing a tax loophole that allowed crypto traders to harvest tax losses in ways not permitted for stock investors.</li>
</ul>
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46248538/bitcoin-ethereum-solana-treasury-companies-need-to-manage-market-volatility-franklin-templeton-report-warns">Bitcoin, Ethereum, Solana Treasury Companies Need To Manage Market Volatility, Franklin Templeton Report Warns</a>
<ul class="wp-block-list">
<li>The bill also introduces a mark-to-market tax election for digital asset dealers and traders, providing consistent treatment with their securities and commodities counterparts.</li>
<li>For miners and stakers, income recognition would be deferred until assets are sold, addressing liquidity concerns for those taxed on unrealized gains.</li>
<li>Additionally, the bill would remove the appraisal requirement for charitable donations of actively traded digital assets, encouraging more philanthropy from crypto holders.</li>
</ul>
The Congressional Joint Committee on Taxation estimates the proposed reforms would generate about $600 million in net revenue over the 2025-2034 period.
What&#8217;s Next: Lummis invited public feedback on the bill, signaling her intention to build bipartisan support as she works to advance the legislation through Congress.
The Wyoming Republican's new crypto tax proposal closely mirrors the measures she previously attempted to include in a broader legislative package introduced earlier this week.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46244196/bitcoin-ethereum-poised-for-bullish-july-experts-say-but-only-one-is-underowned">Bitcoin, Ethereum Poised For Bullish July, Experts Say, But Only One Is &#8216;Underowned&#8217;</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Crypto Tax Loopholes Closing? A Look Inside 'Bitcoin Senator' Lummis' New Bill

Morgan Stanley analyst Manan Gosalia upgrades Valley Ntl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VLY#NASDAQ">VLY</a>) from Equal-Weight to Overweight and raises the price target from $10 to $11.

Upgrades

Morgan Stanley Upgrades Valley Ntl to Overweight, Raises Price Target to $11

U.S. stocks surged to new record highs on Thursday, with Wall Street celebrating stronger-than-expected labor market data ahead <a href="https://www.benzinga.com/markets/economic-data/25/07/46244105/june-jobs-report-nonfarm-payroll-adp-data">of the July 4 holiday.</a>
The S&amp;P 500 was eyeing 6,300, while the Nasdaq 100 climbed to 22,860. The Dow Jones Industrial Average also rallied, coming close to 44,900 — just shy of its January peak. Small caps joined the rally, with the Russell 2000 up nearly 1%.
Investor sentiment was boosted by June's nonfarm payrolls report, which showed the U.S. economy added 147,000 jobs — well above the 110,000 forecast. The data helped ease concerns stoked by a weak private payroll report just a day earlier.
Tech stocks led the charge, with the so-called Magnificent Seven reaching a combined market cap of $18.1 trillion. NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) solidified its lead as the world's most valuable company, surpassing a $3.9 trillion valuation, ahead of Microsoft Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NYSE">MSFT</a>) at $3.7 trillion.
Gains were broad-based across sectors, with only consumer staples slipping 0.1%. Technology and financials outperformed.
In bond markets, Treasury yields rose for a second straight session. The 30-year yield hit 4.85% as the U.S. Senate-passed "One Big Beautiful Bill" advanced to the House.
The upbeat jobs report also lifted the U.S. dollar. The DXY index gained 0.4%, with traders scaling back expectations for a rate cut in July — now pricing in just a 7% chance, down from 25% the day before.
Commodities came under pressure as the dollar strengthened. Gold fell 0.5%, oil slipped 1% and copper declined 1.1%.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) held steady near $109,700.
<h1 class="wp-block-heading">Thursday&#8217;s Performance In Major U.S. Indices, ETFs</h1>
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day chg. %</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>22,867.69</td>
<td>1.0%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>6,281.57</td>
<td>0.9%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>44,864.37</td>
<td>0.9%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,244.57</td>
<td>0.8%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated by 12:50 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul class="wp-block-list">
<li>The&nbsp;Vanguard S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOO#NYSE">VOO</a>) rose 0.9% to $575.03.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) rose 0.9% to $448.52.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;rallied 1% to $555.99.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) rose 0.9% to $222.99.</li>
<li>The&nbsp;Technology&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) outperformed, up 1.5%; the&nbsp;Consumer Staples&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>) lagged, down 0.1%.</li>
</ul>
<h1 class="wp-block-heading">Thursday&#8217;s Stock Movers</h1>
<ul class="wp-block-list">
<li>Datadog Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDOG#NASDAQ">DDOG</a>) stock was up 14.92% at $155.15 after news of its upcoming addition to the S&amp;P 500 and a Wedbush price target hike from $140 to $170.</li>
<li>Lennar Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>) fell 4.09% to $110.12 as stronger-than-expected jobs data dampened hopes for Fed rate cuts.</li>
</ul>
Read Now:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46225431/alphabet-stock-google-analysis-valuations-outlook">This Magnificent 7 Stock Is Absurdly Cheap – It Probably Won&#8217;t Stay That Way For Long</a> Photo: Shutterstock<a href="https://www.benzinga.com/markets/tech/25/07/46225431/alphabet-stock-google-analysis-valuations-outlook"> </a></li>
</ul>

Equities

Macro Economic Events

Broad U.S. Equity ETFs

Commodities

Economics

Tech

ETFs

$BTC

DDOG

SPDR Dow Jones Industrial Average ETF Trust

MSFT

Wall Street Soars To New Highs, Magnificent 7 Top $18 Trillion: What's Moving Markets Thursday?

Morgan Stanley analyst Maxwell Skor assumes Ascendis Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASND#NASDAQ">ASND</a>) with a Overweight rating and announces Price Target of $250.

ASND

Morgan Stanley Assumes Ascendis Pharma at Overweight, Announces Price Target of $250

While Jim Cramer is staying far away, some contrarian investors are leaning in. Nebius Group NV (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBIS#NASDAQ">NBIS</a>), a lesser-known <a href="https://www.benzinga.com/topic/artificial-intelligence">AI infrastructure startup</a> with Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) backing and Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)-level ambition, is quietly building one of the most intriguing bets in autonomous mobility and decentralized AI. 
And that makes it the perfect "Inverse Cramer" play.
Read Also: <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/06/46165787/cramer-praises-monster-beverage-as-smoking-hot-warns-investors-about-this-ai-stock">Cramer Praises Monster Beverage As &#8216;Smoking Hot,&#8217; Warns Investors About This AI Stock</a>
<h2 class="wp-block-heading">Uber's Autonomous Sidekick: Nebius&#8217; Avride</h2>
At the heart of Nebius is its U.S.-based subsidiary, Avride Inc., which began life in 2020 as a spin-off from Yandex's self-driving car unit. Today, Avride is powering real-world robotaxis and delivery bots for Uber Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) and Uber Eats &#8211; with operations already live in Austin, Dallas, and Jersey City.
Think of it as Tesla's software brain meets Nvidia's compute muscle, but focused on the "infrastructure stack" of autonomous mobility. Avride's self-driving vehicles—retrofitted Hyundai Ioniq 5s—are packed with lidars, radars, and custom compute hardware. The company is also deploying sidewalk-speed delivery robots that cross streets, navigate traffic lights, and are already in action from the U.S. to Seoul.
<h2 class="wp-block-heading">The Hyundai Catalyst</h2>
In March 2025, Nebius struck a strategic partnership with Hyundai to develop commercial robotaxis, adding another heavyweight to its corner. Meanwhile, all manufacturing of its delivery robots is happening in Taiwan—giving it supply chain muscle to match its technical stack.
But Nebius isn't just about the vehicles—it's about controlling the AI infrastructure behind them. With Nvidia's blessing and without the baggage of legacy automakers, Nebius is aiming to become the sovereign AI operating system for autonomous mobility, one city and one robot at a time.
And then there&#8217;s the kicker: Jim Cramer <a href="https://www.youtube.com/watch?v=8CqSagdY6QI">isn't buying</a> in. The CNBC host recently passed on the stock, which for <a href="https://x.com/DailyInvestin/status/1940430021434433819">some</a> investors is a bullish signal in itself. In a market chasing hype, Nebius is building. Quietly. Globally. Relentlessly.
If you&#8217;re hunting for the next Tesla-style moonshot with Nvidia pedigree &#8211; and like a little Cramer-contrarianism on the side &#8211; Nebius might just be your AI dark horse.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/45951960/golden-cross-alert-nvidia-backed-ai-stock-just-broke-out-is-this-the-next-big-winner">Golden Cross Alert: Nvidia-Backed AI Stock Just Broke Out &#8211; Is This The Next Big Winner?</a></li>
</ul>
Image: Shutterstock

Long Ideas

Trading Ideas

NBIS

UBER

The Inverse Cramer AI Play: How Nebius Combines Tesla Vibes With Nvidia Muscle

Morgan Stanley analyst Maxwell Skor assumes Sana Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANA#NASDAQ">SANA</a>) with a Overweight rating and announces Price Target of $12.

SANA

Morgan Stanley Assumes Sana Biotechnology at Overweight, Announces Price Target of $12

Wall Street is basking in record highs as the S&amp;P 500 breaks above 6,300 ahead of the July 4 holiday, but just as traders reach for the champagne, a popular market indicator is <a href="https://www.benzinga.com/trading-ideas/technicals">starting to flash red.</a>
<h2 class="wp-block-heading">S&amp;P 500&#8217;s RSI Enters Overbought Territory: Why It Matters</h2>
The S&amp;P 500&#8217;s 14-day Relative Strength Index (RSI), a momentum oscillator that measures the speed and magnitude of price movements, surged to 75.62 on Wednesday, well into the overbought zone above 70.
The RSI ranges from 0 to 100, and traders use it to gauge whether an asset is overbought or oversold. While it doesn&#8217;t predict direction, history shows it often coincides with key market turning points.
In fact, in several recent cases where the S&amp;P 500's RSI hit similarly overbought levels, the index was soon met with sharp and swift pullbacks.
<ul class="wp-block-list">
<li>July 2024: RSI spiked above 75, and the index dropped 10% from 5,660 to August 6</li>
<li>July 2023: RSI flagged overbought, and the S&amp;P 500 slid 10% through late October</li>
<li>September 2020: RSI hit 83 before a rapid 10% decline that same month. </li>
<li>January 2018: RSI hit climbed to 86 after a 7% rally. The index then plunged 12% in just nine trading days during early February.</li>
</ul>
Still, the RSI is not a crystal ball.
In December 2023, the indicator was also overbought, but the S&amp;P 500 – as tracked by the Vanguard S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) – kept climbing and added over 15% until April 2024.
Similarly, in December 2019, a reading of 78 did little to slow momentum until COVID-19, a rather unpredictable event, caused the market to crash two months later.
While the RSI's track record shows that overbought conditions can precede sharp pullbacks, it's not a guaranteed signal — especially in a market driven by strong momentum, AI optimism, and resilient economic data. Still, with the S&amp;P 500 at record highs and sentiment running hot, traders may want to keep one eye on the technicals as they celebrate the holiday rally.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="529" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/03115457/image-45-1024x529.png" alt="" class="wp-image-972359" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/03115457/image-45-1024x529.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/03115457/image-45-300x155.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/03115457/image-45-768x397.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/03115457/image-45-1536x794.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/03115457/image-45-2048x1059.png 2048w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46225431/alphabet-stock-google-analysis-valuations-outlook">This Magnificent 7 Stock Is Absurdly Cheap – It Probably Won&#8217;t Stay That Way For Long </a></li>
</ul>
Photo: Shutterstock

Technicals

The S&P 500 Sank 10% The Last Time This Warning Flashed

Reported GAAP earnings and adjusted non-GAAP earnings for the second quarter of 2025 are expected to include acquired IPR&amp;D and milestones expense of $823 million on a pre-tax basis, representing an unfavorable impact of $0.42 to both GAAP diluted earnings per share and adjusted non-GAAP diluted earnings per share. Results for the quarter ended June 30, 2025 have not been finalized and are subject to our financial statement closing procedures. There can be no assurance that our final results will not differ from these preliminary estimates.

&nbsp;
While acquired IPR&amp;D and milestones expense may be incurred upon execution of collaborations, licensing agreements, and other asset acquisitions, AbbVie does not forecast acquired IPR&amp;D and milestones expense due to uncertainty of the future occurrence and timing of these transactions. Adjusted diluted earnings per share guidance for 2025 previously announced on April&nbsp;25, 2025 excluded the impact of acquired IPR&amp;D and milestones expense that may be incurred beyond the first quarter of 2025. AbbVie&#39;s full-year 2025 adjusted diluted earnings per share guidance range, including the impact of second quarter 2025 acquired IPR&amp;D and milestones expense, is $11.67 - $11.87. AbbVie&#39;s second quarter 2025 adjusted diluted earnings per share guidance range, including the impact of second quarter 2025 acquired IPR&amp;D and milestones expense, is&nbsp;

Guidance

ABBV

AbbVie Expects $823M Acquired IPR&D And Milestones Expense In Q2 2025, Reducing Non-GAAP Diluted EPS By $0.42 To $2.84-$2.88 For Q2 2025;  FY25 Adjusted Diluted EPS Guidance Range, Including The Impact Of Q2 2025 Acquired IPR&D And Milestones Expense, Is $11.67-$11.87

General

REE Automotive Receives Nasdaq Letter Regarding Minimum Bid Price

Investors with a lot of money to spend have taken a bearish stance on DeFi Development (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DFDV#NASDAQ">DFDV</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with DFDV, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 10 options trades for DeFi Development.
This isn't normal.
The overall sentiment of these big-money traders is split between 40% bullish and 50%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $48,000, and 9, calls, for a total amount of $415,876.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $12.5 to $25.0 for DeFi Development over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for DeFi Development's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across DeFi Development's significant trades, within a strike price range of $12.5 to $25.0, over the past month.
<h3>DeFi Development 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751562692_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DFDV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/18/26</td>
<td>$13.6</td>
<td>$10.3</td>
<td>$10.6</td>
<td>$25.00</td>
<td>$97.0K</td>
<td align="right">121</td>
<td align="right">95</td>
</tr>
<tr>
<td>DFDV</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$4.3</td>
<td>$3.9</td>
<td>$4.3</td>
<td>$25.00</td>
<td>$90.3K</td>
<td align="right">962</td>
<td align="right">210</td>
</tr>
<tr>
<td>DFDV</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$8.5</td>
<td>$7.0</td>
<td>$7.5</td>
<td>$25.00</td>
<td>$62.2K</td>
<td align="right">522</td>
<td align="right">377</td>
</tr>
<tr>
<td>DFDV</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/18/26</td>
<td>$17.5</td>
<td>$14.1</td>
<td>$15.0</td>
<td>$25.00</td>
<td>$48.0K</td>
<td align="right">19</td>
<td align="right">32</td>
</tr>
<tr>
<td>DFDV</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$7.5</td>
<td>$6.9</td>
<td>$7.5</td>
<td>$25.00</td>
<td>$35.2K</td>
<td align="right">522</td>
<td align="right">157</td>
</tr>
</tbody>
</table>

<h3>About DeFi Development</h3>
DeFi Development Corp is an AI-powered online platform that connects the commercial real estate industry by providing data and software subscriptions as well as value-add services to multifamily and commercial property professionals.
Following our analysis of the options activities associated with DeFi Development, we pivot to a closer look at the company's own performance.
<h3>Current Position of DeFi Development</h3>
<ul>
<li>With a volume of 2,047,894, the price of DFDV is up 2.26% at $20.85. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 12 days.</li>
</ul>
<h3>Professional Analyst Ratings for DeFi Development</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $45.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $45. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest DeFi Development options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

DFDV

Spotlight on DeFi Development: Analyzing the Surge in Options Activity

Press Releases

Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th

Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting

Anixa Biosciences CEO Provides Letter to Shareholders Outlining Significant Progress and Advancement Towards Potentially Transformative Milestones

Anixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer Vaccine

Anixa Biosciences' Breast Cancer Vaccine Featured in NewsNation Interview

Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the ESMO Gynaecological Cancers Congress 2025

Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage

Opinion

As Public Cancer Funding Wavers, Oncology's Brightest Breakthroughs Are Coming From Industry

Anixa Biosciences to Host an Investor Webcast on June 26, 2025

Anixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial

Comments

Anixa Biosciences

Actualités

Dernières nouvelles pour Anixa Biosciences (NASDAQ:ANIX) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL